Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease

被引:5
|
作者
Sweeney, Jacob R. [1 ]
Crawford, Carl, V [2 ]
Yantiss, Rhonda K. [3 ]
机构
[1] Cleveland Clin, Dept Pathol & Lab Med, Cleveland, OH 44106 USA
[2] Weill Cornell Med, Div Gastroenterol & Hepatol, New York, NY USA
[3] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA
关键词
infection; Crohn disease; ulcerative colitis; pseudomembranous colitis; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE EPIDEMIOLOGY; INFECTION; SOCIETY; UPDATE; COLECTOMY; DIARRHEA; ADULTS; RISK;
D O I
10.1111/his.14702
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims Patients with inflammatory bowel disease (IBD) are at increased risk for Clostridioides difficile infection, although clinically important infections can be difficult to recognise. C. difficile infection does not produce pseudomembranes when it occurs in IBD patients. These individuals may also be colonised by the organism, in which case diarrhoeal symptoms are not necessarily attributed to C. difficile. We performed this study to determine whether any features distinguished C. difficile-associated colitis from an IBD flare. Methods and results We reviewed the clinical, endoscopic and biopsy findings from 50 patients with established IBD and worsening diarrhoea, including 22 with concurrent positive C. difficile stool toxin polymerase chain reaction (PCR) assays and 28 with negative C. difficile assay results. We found that C. difficile-infected patients had symptoms and endoscopic findings that were indistinguishable from active IBD. Although most biopsy samples from patients with C. difficile infection showed chronic active colitis indistinguishable from IBD, some displayed neutrophilic infiltrates unaccompanied by plasma cell-rich inflammation involving superficial (41%) and crypt (18%) epithelium as well as neutrophilic infiltrates within lamina propria distant from foci of cryptitis (32%). All three of these features were significantly more common among infected than uninfected patients (4, 0 and 4%; P = 0.002, P = 0.03 and P = 0.02, respectively). Conclusions Although colonic biopsies from IBD patients with C. difficile infection usually lack features that aid distinction from colitic flares, some cases show an acute colitis pattern not seen in IBD alone. When identified in biopsies from symptomatic IBD patients, these changes should alert pathologists to the possibility of this clinically important infection.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 50 条
  • [1] Histologic Features of Clostridioides difficile Colitis in Patients with Inflammatory Bowel Disease
    Sweeney, Jacob
    Crawford, Carl
    Chen, Zhengming
    Jessurun, Jose
    Yantiss, Rhonda
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 775 - 776
  • [2] Histologic Features of Clostridioides difficile Colitis in Patients with Inflammatory Bowel Disease
    Sweeney, Jacob
    Crawford, Carl
    Chen, Zhengming
    Jessurun, Jose
    Yantiss, Rhonda
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 775 - 776
  • [3] SPECIFIC FEATURES OF CLOSTRIDIUM DIFFICILE COLITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Mihai, Catalina
    Stefanescu, Gabriela
    Gogalniceanu, Petrut
    Anton, Carmen
    Dranga, Mihaela
    Jigaranu, Olivia
    Balmus, Ioana-Miruna
    Timofte, Daniel
    Ciobica, Alin
    Prelipcean, Cristina Cijevschi
    ARCHIVES OF BIOLOGICAL SCIENCES, 2015, 67 (01) : 147 - 153
  • [4] Management of Clostridioides difficile infection in patients with inflammatory bowel disease
    Khanna, Sahil
    INTESTINAL RESEARCH, 2021, 19 (03) : 265 - 274
  • [5] Risk of Clostridioides difficile infection in patients with inflammatory bowel disease
    Martinez Lozano, H.
    Saralegui Gonzalez, P.
    Fueyo Pelaez, P. R.
    Garcia Garcia, A.
    Miranda-Bautista, J.
    Reigadas Ramirez, E.
    Alcala Hernandez, L.
    Munoz Garcia, P.
    Marin-Jimenez, I.
    Menchen, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2044 - I2044
  • [6] CLOSTRIDIOIDES DIFFICILE TREATMENT FOR PATIENTS WITH INFLAMMATORY BOWEL
    Lou, Susan
    Wongjarupong, Nicha
    Ouchveridze, Evguenia
    McCabe, Robert P.
    Vaughn, Byron P.
    GASTROENTEROLOGY, 2022, 162 (07) : S902 - S903
  • [7] Fidaxomicin for Treatment of Clostridioides difficile Infection in Patients With Inflammatory Bowel Disease
    Travers, Paul
    Koop, Andree H.
    Khanna, Sahil
    Pardi, Darrell S.
    Farraye, Francis A.
    Hashash, Jana G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S598 - S599
  • [8] Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease
    Koop, Andree H.
    Travers, Paul M.
    Khanna, Sahil
    Pardi, Darrell S.
    Farraye, Francis A.
    Hashash, Jana G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (11) : 1910 - 1916
  • [9] Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease
    Dalal, Rahul S.
    Allegretti, Jessica R.
    CURRENT OPINION IN GASTROENTEROLOGY, 2021, 37 (04) : 336 - 343
  • [10] Clostridioides difficile Infection in Children With Inflammatory Bowel Disease
    Chandrakumar, Abin
    Zohni, Hussein
    El-Matary, Wael
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : 1700 - 1706